<div class="embed-responsive embed-responsive-16by9"><iframe width="640" height="360" style="max-width: 100%;max-height: 100%; border:none;" src="https://www.oncologytube.com/videoEmbed/38288/venetoclax-rituximab-venr-in-relapsed-refractory-r-r-cll-ash19-ash?channelName=ash" frameborder="0" allowfullscreen="allowfullscreen" allow="autoplay" scrolling="no">iFrame is not supported!</iframe></div>

$Venetoclax-Rituximab (VenR) in Relapsed Refractory (R/R) CLL #ASH19 #ASH$ 0:03:16

Venetoclax-Rituximab (VenR) in Relapsed Refractory (R/R) CLL #ASH19 #ASH

User Photo

ash

1 year

40 Views

Share Report Add to 0 0

Embed (Iframe):

<div class="embed-responsive embed-responsive-16by9"><iframe width="640" height="360" style="max-width: 100%;max-height: 100%; border:none;" src="https://www.oncologytube.com/videoEmbed/38288/venetoclax-rituximab-venr-in-relapsed-refractory-r-r-cll-ash19-ash?channelName=ash" frameborder="0" allowfullscreen="allowfullscreen" allow="autoplay" scrolling="no">iFrame is not supported!</iframe></div>

Embed (Object):

<div class="embed-responsive embed-responsive-16by9"><object width="640" height="360"><param name="movie" value="https://www.oncologytube.com/videoEmbed/38288/venetoclax-rituximab-venr-in-relapsed-refractory-r-r-cll-ash19-ash?channelName=ash"></param><param name="allowFullScreen" value="true"></param><param name="allowscriptaccess" value="always"></param><embed src="https://www.oncologytube.com/videoEmbed/38288/venetoclax-rituximab-venr-in-relapsed-refractory-r-r-cll-ash19-ash?channelName=ash" allowscriptaccess="always" allowfullscreen="true" width="640" height="360"></embed></object></div>

Link (HTML):

<a href="https://www.oncologytube.com/v/38288?channelName=ash"><img src="https://www.oncologytube.com/videos/_YPTuniqid_5df290094bc053.32928952.jpg?1576177677">Venetoclax-Rituximab (VenR) in Relapsed Refractory (R/R) CLL #ASH19 #ASH</a>

Link (BBCode):

[url=https://www.oncologytube.com/v/38288?channelName=ash][img]https://www.oncologytube.com/videos/_YPTuniqid_5df290094bc053.32928952.jpg?1576177677[/img]Venetoclax-Rituximab (VenR) in Relapsed Refractory (R/R) CLL #ASH19 #ASH[/url]

Sign in now!

Permanent Link

URL Friendly (SEO)

Current Time (SEO)

Category:

Chronic Lymphocytic Leukemia

Description:

John Seymour, PhD of @PeterMacCC discusses year analysis of murano study confirms sustained benefit of time-limited venetoclax-rituximab (VenR) in relapsed refractory (R/R) chronic lymphocytic leukemia (CLL).

Up Next Autoplay

>